Coferon

Coferon utilizes bio-orthogonal linker chemistry technology to deliver therapeutic molecules through self-assembling components within the target tissue. The company is currently engaged in research and development projects in the field of epigenetic regulation (with an initial focus on the BRD family) and anti-infective drugs. Coferon is located in the Long Island High Technology Incubator on the campus of Stony Brook University in Stony Brook, New York.